Stability indicating reversed-phase high-performance liquid chromatographic method for the determination of rizatriptan benzoate in bulk powder and in pharmaceutical formulations

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 1, Issue 2, 2010, Pages 385-395

  Jagtap, Sachin S ^a   Gopu, C L ^a   Mahadik, Kakasabeb R ^a   Mahadik, Mahadev V ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Degradation products; Purity evaluation; Rizatriptan benzoate; RP HPLC; Validation

Indexed keywords

BUFFER; METHANOL; PHOSPHORIC ACID; RIZATRIPTAN; SODIUM DIHYDROGEN PHOSPHATE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DECOMPOSITION; DRUG DEGRADATION; DRUG DETERMINATION; DRUG HYDROLYSIS; DRUG OXIDATION; DRUG SCREENING; DRUG STABILITY; ENVIRONMENTAL TEMPERATURE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PH; PHOTOLYSIS; POWDER; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; TABLET FORMULATION; TEMPERATURE STRESS; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

EID: 79952579546     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Goldberg MR, Lee Y, Ermlich S. J Clin Pharmacol 2000; 40: 74-83.
2. Bou J, Domenech T, Puig J, Heredia A, Gras J, Fernandez-Forner D, Beleta J. Palacios JM. Eur J Pharmacol 2000; 410: 33-41.
3. Emile H, Joseph H, Hashmonai D. J Emer Med 2003; 3: 245-249.
4. Sharma A, Jusko WJ, Fulmor IE. J Clin Pharmacol 1999; 39: 685-694.
5. Chen Y, Miao H, Lin M, Fan G, Hong Z. J Chromatogr 2006; 844: 268-277.
6. ICH Harmonized Tripartite Guidelines, Validation ofanalytical procedure methodology, 6th November, 1996.
7. ICH Harmonized Tripartite Guidelines, Text on Validation of analytical procedure step-4 Q2A, October, 1994.
8. Joseph SR, Bharathi CH, Joseph P, Naveen Kumar P, Sharma HK, Kalpesh. J Pharm Biomed 2009; 1: 1156-162.
9. Zecevic M, Jocic B, Zivanovic L, Protic A. J Chromatogr 2008; 0009-5893: 911-918.
10. Vyas KP, Halpin RA, Geer LA. J Drug Met Disp 2000; 28: 89-95.